| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMEM39A mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TMEM39A mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMEM39A mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMEM39A mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TMEM39A mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of TMEM39A mRNA | CTD | PMID:21715664 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM39A gene | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of TMEM39A mRNA | CTD | PMID:18353800 |
| copper atom | multiple interactions | ISO | RGD:1353039 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TMEM39A mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1353039 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of TMEM39A mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1353039 | 6480464 | Copper Sulfate results in decreased expression of TMEM39A mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | ISO | RGD:1353039 | 6480464 | Cyclosporine results in increased expression of TMEM39A mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1353039 | 6480464 | Cyclosporine results in increased expression of TMEM39A mRNA | CTD | PMID:20106945 PMID:21632981 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of TMEM39A mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1306421 | 6480464 | Dibutyl Phthalate results in increased expression of TMEM39A mRNA | CTD | PMID:21266533 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM39A gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TMEM39A gene | CTD | PMID:20938992 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMEM39A mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of TMEM39A mRNA | CTD | PMID:17426115 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of TMEM39A mRNA | CTD | PMID:21278054 |
| sulindac | increases expression | ISO | RGD:1353039 | 6480464 | Sulindac results in increased expression of TMEM39A mRNA | CTD | PMID:11906190 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of TMEM39A mRNA | CTD | PMID:17292431 |